HDL from humans with type 2 diabetes versus controls has similar ApoM content, but HDL from those with diabetes is less efficient at preventing endothelial TNF-α expression and activating eNOS, functions that correlate with plasma S1P levels (17). This evidence concerns the gene APOM and type 2 diabetes mellitus.